DarioHealth Corp. Common Stock
DRIO US23725P2092
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. Its cross-functional team operates at the intersection of life sciences, behavioral science, and software technology to deliver seamlessly integrated and highly engaging digital therapeutics interventions. Also platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
Annual Performance 1
| 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| -16% | -69% | -60% | -53% | 0% |
Annual Insiders Turnover, USD 2
1 annual and historical performance metrics are recalculated on a daily basis;
2 represents the total value of insider transactions (both buying and selling);
Insider Activity
| Person | Price | Shares | Total | Published | Completed |
|---|---|---|---|---|---|
| Nelson Steven Charles CCO |
0.53 USD |
40,000 Bought |
21,200 USD |
27/08/2025 | 27/08/2025 |
| Nelson Steven Charles CCO |
0.91 USD |
5,000 Bought |
4,546 USD |
12/11/2024 | 12/11/2024 |
| Nelson Steven Charles CCO |
0.80 USD |
5,000 Bought |
4,023 USD |
10/09/2024 | 11/09/2024 |
| Nelson Steven Charles CCO |
0.84 USD |
5,000 Bought |
4,221 USD |
10/09/2024 | 10/09/2024 |
| Nelson Steven Charles CCO |
0.80 USD |
5,000 Bought |
4,000 USD |
05/09/2024 | 09/09/2024 |
| Nelson Steven Charles CCO |
0.84 USD |
5,000 Bought |
4,201 USD |
05/09/2024 | 06/09/2024 |
| Nelson Steven Charles CCO |
0.82 USD |
5,000 Bought |
4,091 USD |
05/09/2024 | 05/09/2024 |
| Raphael Erez CEO |
0.88 USD |
5,000 Bought |
4,400 USD |
27/08/2024 | 27/08/2024 |
| Nelson Steven Charles CCO |
0.95 USD |
5,000 Bought |
4,750 USD |
21/08/2024 | 23/08/2024 |
| Nelson Steven Charles CCO |
0.95 USD |
5,000 Bought |
4,725 USD |
21/08/2024 | 22/08/2024 |